<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250327</url>
  </required_header>
  <id_info>
    <org_study_id>P080205</org_study_id>
    <nct_id>NCT01250327</nct_id>
  </id_info>
  <brief_title>Medico-economic Evaluation of a Non-chirurgical Pulmonary Valve Replacement (REVALV)</brief_title>
  <acronym>REVALV</acronym>
  <official_title>Medico-economic Evaluation of a Non-chirurgical Pulmonary Valve Replacement for the Treatment of Lesions of the Ventricular Outflow Tract.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective interventional study is designed to evaluate the cost/advantage ratio in the
      treatment of lesions of the right ventricular outflow tract using transcatheter pulmonary
      valved stent (Melody).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rational : transcatheter valve insertion is a new technique enlarging the armamentarium of
      the treatment of RVOT obstruction and insufficiency. It real place as compared to bare stent
      implantation and surgery of the RVOT remains unknown.

      Main objective : evaluate the cost of the procedure as compared with conventional technique.

      Design : multicenter intervention prospective study. Population : 180 patients in three arms
      (3*60).

      End point criteria :

        -  Primary : cost

        -  Secondary : rate of reoperation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost induced by the transcatheter pulmonary valve insertion as compared to conventional surgical and insertion of a bare metal stent 24 months after insertion.</measure>
    <time_frame>24 months after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedure success rate</measure>
    <time_frame>24 months after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Does the patient need to be operated again?</measure>
    <time_frame>24 months after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Dysfunction of the Prosthetic Conduct</condition>
  <condition>Lesions of the Right Ventricular Outflow Tract</condition>
  <arm_group>
    <arm_group_label>Melody</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>insertion of a pulmonic valved stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bare stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>insertion of a bare metal stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional surgery methode.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Melody</intervention_name>
    <description>insertion of a pulmonic valved stent</description>
    <arm_group_label>Melody</arm_group_label>
    <other_name>insertion of a pulmonic valved stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bare stent</intervention_name>
    <description>insertion of a bare metal stent</description>
    <arm_group_label>Bare stent</arm_group_label>
    <other_name>insertion of a bare metal stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>conventional surgery methode</description>
    <arm_group_label>Surgery</arm_group_label>
    <other_name>conventional surgery methode</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        for the study:

          -  Lesions of the right ventricular outflow tract in need of surgery for stenosis or
             regurgitation

        for the Melody arm:

          -  A 5 to 70 years old patient

          -  Weight &gt;= 30kg

          -  RVOT &lt;= to 22mm

          -  Patient with a dysfunction circumferential prosthetic conduct of diameter &gt;= to 16mm.

        Exclusion Criteria:

          -  Vein anatomy incompatibility with a 22Fr delivery health

          -  Left heart implantation

          -  RVOT incompatible with a anchoring of the stent (lik in patient operated of a
             tetralogy of fallot)

          -  Coronary anomaly with a coronary artery naer the RVOT

          -  Sever obstruction of the RVOT incompatible with balloon expansion

          -  Central vein obstruction

          -  Ongoing infection

          -  Active endocarditis

          -  Allergy for heparin or aspirin

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boudjemline Younes, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>right ventricular outflow tract</keyword>
  <keyword>endovascular valve insertion</keyword>
  <keyword>economic evaluation</keyword>
  <keyword>valved stent</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

